Skip to main content
Erschienen in: BMC Cardiovascular Disorders 1/2020

Open Access 01.12.2020 | Research article

Chinese ASCVD risk equations rather than pooled cohort equations are better to identify macro- and microcirculation abnormalities

verfasst von: Qiaowei Li, Fan Lin, Zhonghai Gao, Feng Huang, Pengli Zhu

Erschienen in: BMC Cardiovascular Disorders | Ausgabe 1/2020

Abstract

Background

We hypothesized that discriminating the early subclinical organ damage would serve as a great opportunity for prevention against atherosclerotic cardiovascular disease (ASCVD). Brachial-ankle pulse wave velocity (baPWV), low retinal vascular fractal dimension, and albuminuria are surrogates of subclinical vascular changes.

Methods

The aim of this study was to use Pooled Cohort Equations (PCE) and ASCVD risk equations derived from “Prediction for ASCVD Risk in China project (CHINA-PAR)” to observe the prevalence of macro- and microcirculation abnormalities. A total of 2166 subjects were involved. Characteristics were investigated using questionnaire and physical examinations. We calculated the urine albumin to creatinine ratio (UACR). The baPWV was measured using a fully automatic arteriosclerosis detector. The retinal vascular fractal dimension was measured by a semiautomated computer-based program. The 10-year ASCVD risk was estimated using the PCE and CHINA-PAR model.

Results

The cut-off values for the elevated baPWV were 2.82 and 2.92% in the PCE model and CHINA-PAR model, respectively, with nearly 85% sensitivity and an average specificity of 74%. For low retinal fractal dimension, at the cut-off point of 3.8%, we acquired an acceptable sensitivity of 66.27–68.24% and specificity of 62.57–67.45%. All the C-statistics presented a significant improvement from the PCE model to the CHINA-PAR model (P < 0.05). For all categories—net reclassification improvement (NRI) values were significant and clearly varied (0.329, 0.183, and 0.104, respectively) depending on the cut-off set at 3%.

Conclusion

Our study demonstrated that the CHINA-PAR equations rather than PCE could provide better identification of macro- and microcirculation abnormalities. A lower cut-off point for the subclinical vascular changes may be selected in a population from southeast China.
Hinweise

Supplementary information

Supplementary information accompanies this paper at https://​doi.​org/​10.​1186/​s12872-020-01425-0.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
CVD
Cardiovascular disease
PCE
Pooled cohort equations
ASCVD
Atherosclerotic CVD
CHINA-PAR
Prediction for ASCVD risk in China project
baPWV
Brachial-ankle pulse wave velocity
TC
Total cholesterol
HDL-C
High-density lipoprotein cholesterol
LDL-C
Low-density lipoprotein cholesterol
HbA1c
Glycosylated hemoglobin
BMI
Body mass index
UACR
Urine albumin to creatinine ratio
eGFR
The estimated glomerular filtration rate
ROC
Receiver operating characteristic
NRI
Net reclassification improvement

Background

Cardiovascular disease (CVD) produces severe health and economic burden in China and globally [1, 2]. There were an estimated 93.8 million cases of CVD overall during 2016 in China, which is more than twice the cases that were reported in 1990 [1]. For better prevention of CVD and individualized therapy, several risk factors have been established. In 2013, the American College of Cardiology and the American Heart Association developed the Pooled Cohort Equations (PCE) to estimate the 10-year risk of developing a first hard atherosclerotic CVD (ASCVD) event (defined as the first occurrence of nonfatal myocardial infarction, coronary heart disease, death, or stroke) [3]. Due to ethnic differences, estimated risks may be over-estimated in Asian-American populations in the PCE model. A new tool to conduct ASCVD risk prediction called the Prediction for ASCVD Risk in China project (CHINA-PAR) was subsequently developed in 2016 [4]. The CHINA-PAR equations are based on traditional major risk factors with several new variables, validated by 4 Chinese cohorts, and aimed to serve as valuable predictor of ASCVD risk in the general Chinese population. However, studies have shown controversial results with the CHINA-PAR model. It outperformed PCE in ASCVD risk prediction in a rural northern Chinese population [5] but underestimated the risk in Mongolians [6]. Thus, further validation of ASCVD risk predictions in other Chinese populations needs to be performed.
ASCVD has a latency of many years and produces multiple subclinical manifestations during its progression. Therefore, we hypothesized that discriminating the early macro- and microvascular subclinical organ damage would provide a great opportunity to develop preventative interventions. In the macro-circulation, the measurement of arterial stiffness parameters was performed by brachial-ankle pulse wave velocity (baPWV) to predict the risk of future CV events and total mortality, which is recommended by the guidelines for the management of hypertension in Japan [7]. In the microcirculation, low retinal vascular fractal dimension indicates reduced complexity in the branching pattern of the microvasculature, independent of stroke risk factors [8], and albuminuria is associated with retinopathy, stroke, heart failure, and atherosclerosis [912].
Although these methods for early organ damage above are noninvasive, the technical complexity and time consumption may reduce the detection rate. Therefore, we aimed to use the ASCVD risk scores to observe the prevalence of macro- and microcirculation abnormalities in a Chinese population, achieving a more valuable equation by comparing the PCE and CHINA-PAR models.

Methods

Subjects

Our study was based on a cross-sectional study of hypertension conducted from July 2011 to November 2011. A total of 7 coastal villages in Fujian Province were randomly selected in cluster sampling. Voluntary participants aged 30 years or more living in the above selected areas for more than 5 years were enrolled. Subjects without complete data or qualified fundus photographs were excluded. We also excluded subjects previously diagnosed with ASCVD (including myocardial infarction, coronary heart disease and stroke) or with a suspicion of active inflammatory disease. Two thousand one hundred sixty-six subjects were involved finally (Fig. 1). This study was performed according to the World Medical Association Declaration of Helsinki and approved by the Ethics Committee of the Fujian Provincial Hospital. A written informed consent was obtained from all individuals.

Data collection

Questionnaires were administered to collect following variables: age, smoking habits, alcohol consumption, medical history (including hypertension, diabetes, myocardial infarction, cardiomyopathy, congenital heart disease, peripheral vascular disease, congestive heart failure, stroke, acute and chronic inflammatory diseases, malignancy, and hematological disorders), and medications. Participants underwent physical examinations to measure height, weight, waist circumference, hip circumference, and blood pressure. Body mass index (BMI) was calculated as the weight (kg)/height2 (m2). Fasting blood samples were collected for laboratory testing including total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), glycosylated hemoglobin (HbA1c), and serum creatinine. Urinary creatinine and albumin were measured from the morning urine sample. We calculated estimated glomerular filtration rate (eGFR) with the Chronic Kidney Disease Epidemiology Collaboration equation [13]. The urine albumin to creatinine ratio (UACR) was defined as the ratio of urine albumin to urine creatinine [14]. The subjects who had been diagnosed or already took related medication were defined as hypertensive [15]. Participants with a clear history, or were currently taking anti-diabetic medications, or with an HbA1c ≥6.5% were defined as diabetic [16].

Measurement of baPWV

After resting for more than 10 min, the baPWV was measured using a fully automatic arteriosclerosis detector (Colin VP-1000 device; Colin Medical Technology Company, Komaki, Japan) by two professionals. We selected the right baPWV for analysis. The inter- and intra-observer variability coefficients were 0.93 (95% CI: 0.92–0.93) and 0.99 (95% CI: 0.98–0.99), respectively.

Retinal fractal dimension

For documentation of non-mydriatic fundus photographs, two ophthalmologists used digital cameras (Topcon NW-8, TOPCON CORPORATION, Tokyo, Japan, and Nikon D90, Tokyo, Japan) centering on the optic disk with a capturing range of 45°. A semiautomated computer-based program (Singapore I Vessel Assessment version 3.0 software, jointly developed by Singapore National University and Singapore Eye Research Institute, Singapore) was used to measure retinal vascular fractal dimension in the range of 0.5–2 DD from the disc margin. In a random sample of 100 fundus photographs, we found no differences between intra-grader measurements. The intergrader correlation coefficient for Df was 0.90 (95% CI: 0.89–0.90).

Assessment of ASCVD risk

The 10-year ASCVD risk was estimated using the PCE model recommended by the 2013 American College of Cardiology/American Heart Association (ACC/AHA) [3] and the CHINA-PAR model produced based on a Chinese population [4], respectively. The basic equation is \( 1-{{\mathrm{S}}_{10}}^{{\mathrm{e}}^{\left({\mathrm{IndX}}^{\prime}\mathrm{B}-{\mathrm{MeanX}}^{\prime}\mathrm{B}\right)}} \), in which S10 means baseline survival, lndX’B is calculated by sum of “Coeffcient × Value”, and MeanX’B stands for mean of “Coeffcient × Value” (details showed in Supplemental Table 1). The PCE included gender, age, race, diagnosis of diabetes, smoking, treated hypertension, systolic blood pressure, and lipid profile values (TC and HDL-C) as variables. The CHINA-PAR equations contained the major risk factors adopted in the PCE and additional variables including waist circumference, geographic region (northern vs. southern), urbanization (urban vs. rural), and family history of ASCVD.

Definition of macro- and microcirculation abnormalities

The cut-off value for the normal and increased baPWV was 1400 cm/s [17]. The lowest quartile of the retinal vascular fractal dimension was defined as a low fractal dimension. Albuminuria was defined as UACR ≥30 mg/g [14].

Statistical analysis

All statistical analyses were conducted using R version 3.5.3 and MedCalc® statistical software, and a P-value < 0.05 was considered statistically significant. Normally distributed continuous data are given as means ± SDs, skewed distributed continuous data are reported as median (25th, 75th percentiles), categorical variables are presented as the percentage of patients. Receiver operating characteristic (ROC) curves were applied to evaluate macro- and microcirculation abnormalities. Cut-off points were determined according to the Youden index with the best-combined sensitivity and specificity. Prognostic comparisons between models were done using Harrell’s concordance C-statistic. We explored categorical net reclassification improvement (NRI) to evaluate the stratification of effects from the PCE model to the CHINA-PAR model at the cut-off point derived from the ROC.

Results

Table 1 shows characteristics of the study population. A total of 2166 individuals were enrolled in this study, with an average age of 51.91 ± 11.91 years and 37.4% men. The median UACR was 10.17 mg/g (interquartile range 4.13–22.98 mg/g). The mean retinal fractal dimension was 1.37 ± 0.05. The median baPWV for all subjects was 1346 cm/s, with an interquartile range of 1170–1600 cm/s. The prevalence of hypertension, diabetes mellitus, smoking, and drinking were 23.6, 8.5, 19.1, and 15.7%, respectively.
Table 1
Characteristics of study population
subjects, n
2166
age, years
51.91 ± 11.91
systolic BP, mmHg
126.89 ± 21.90
diastolic BP, mmHg
78.53 ± 11.84
WHR
0.85 ± 0.07
BMI, kg/m2
23.83 ± 3.42
total cholesterol, mmol/L
5.03 ± 1.05
HDL-C, mmol/L
1.23 ± 0.33
LDL-C, mmol/L
2.78 ± 0.88
eGFR, ml/min/1.73m2
103.25 ± 33.62
HbA1c, %
5.72 ± 0.68
UACR, mg/g
10.17(4.13, 22.98)
fractal dimension
1.37 ± 0.05
baPWV, cm/s
1346(1170, 1600)
male, n (%)
810(37.4)
hypertension history, n (%)
512(23.6)
diabetes history, n (%)
185(8.5)
smoking, n (%)
414(19.1)
drinking, n (%)
339(15.7)
Normally distributed continuous data are given as mean ± SD, skewed distributed continuous data are reported as median (25th, 75th percentiles), categorical variables are presented as a percentage of patients. BP Blood pressure, WHR Waist-hip rate, BMI Body mass index, HDL-C High density lipoprotein-cholesterol, LDL-C Low density lipoprotein-cholesterol, eGFR Estimated glomerular filtration rate, HbA1c Glycated haemoglobin A1c, UACR Urine albumin-to-creatinine ratio, baPWV Brachial-ankle pulse wave velocity
Cut-off values, sensitivity, and specificity with the highest Youden index are shown in Table 2. The cut-off values for the elevated baPWV were 2.82 and 2.92% in the PCE model and the CHINA-PAR model, respectively, with nearly 85% sensitivity and an average specificity of 74%. For the low retinal fractal dimension, at the cut-off point of 3.8%, we achieved an acceptable sensitivity of 66.27–68.24% and specificity of 62.57–67.45%. However, for albuminuria, neither the PCE model nor the CHINA-PAR model would achieve sensitivity higher than 61.14%. In this case, we set a new cut-off point at 3% for the high-risk category (PCE and CHINA-PAR models) for reclassification.
Table 2
Highest Youden index of macro- and microcirculation abnormalities and corresponding cut-off, sensitivity, and specificity
risk scores
Youden index
cut-off
sensitivity
specificity
elevated baPWV
 PCE
55.97
2.82
84.14
71.84
 CHINA-PAR
62.18
2.92
84.25
77.93
low fractal dimension
 PCE
30.81
3.79
68.24
62.57
 CHINA-PAR
33.72
3.77
66.27
67.45
albuminuria
 PCE
15.00
11.09
35.15
79.85
 CHINA-PAR
18.52
3.06
61.14
57.38
Values are presented as %. baPWV Brachial-ankle pulse wave velocity, PCE Pooled cohort equation recommended by the 2013 American College of Cardiology and American Heart Association guidelines; CHINA-PAR, equations for 10-year ASCVD risk prediction in Chinese populations
The area under the ROC curve calculated for discriminating elevated baPWV was 0.86 for PCE (95% CI: 0.84–0.87) and 0.88 for CHINA-PAR (95% CI: 0.87–0.90). To distinguish the low fractal dimension, the C-statistics were 0.71 (95% CI: 0.69–0.73) for PCE and 0.72 (95% CI: 0.70–0.74) for CHINA-PAR. The C-statistics to detect albuminuria were 0.59 (95% CI: 0.57–0.61) for PCE and 0.61 (95% CI: 0.59–0.63) for CHINA-PAR. All the C-statistics presented a significant improvement from the PCE model to the CHINA-PAR model (P < 0.05). All categorical-NRI values were significant and varied across groups (0.329, 0.183, and 0.104, respectively) depending on the cut-off set at 3%. (Table 3 and Fig. 2).
Table 3
Comparisons of PCE and CHINA-PAR with a difference in AUC and NRI for prediction of macro- and microcirculation abnormalities
 
C-statistics of PCE model (95% CI)
C-statistics of CHINA-PAR model (95% CI)
∆AUC (95% CI)
P
categorical NRI (95% CI)
P
elevated baPWV
0.86 (0.84–0.87)
0.88(0.87–0.90)
0.028(0.020–0.036)
< 0.001
0.329(0.290, 0.368)
< 0.001
low fractal dimension
0.71 (0.69–0.73)
0.72 (0.70–0.74)
0.012 (0.002–0.022)
0.019
0.183(0.137, 0.228)
< 0.001
albuminuria
0.59 (0.57–0.61)
0.61 (0.59–0.63)
0.016 (0.005–0.027)
0.032
0.104(0.053, 0.156)
< 0.001
Cut-off for categorical NRI is 3.00%. PCE, pooled cohort equation recommended by the 2013 American College of Cardiology and American Heart Association guidelines; CHINA-PAR–equations for 10-year ASCVD risk prediction in Chinese populations; AUC Area under the receiver operative curve (C-statistics); CI Confidence interval, NRI Net reclassification improvement; baPWV brachial-ankle pulse wave velocity

Discussion

To our knowledge, our study is the first to validate the incremental value of CHINA-PAR equations against PCE for discriminating macro- and microcirculation abnormalities.
In this cross-sectional study, we assessed the performance of the PCE and CHINA-PAR models for macro- and microcirculation abnormalities in a southern Chinese rural population.
Our results showed that both models showed acceptable discrimination of elevated baPWV and low retinal vascular fractal dimension. Compared to PCE, CHINA-PAR equations showed a significant improvement in the prevalence stratification of macro- and microcirculation abnormalities represented by elevated baPWV, low retinal vascular fractal dimension, and UACR. After resetting the cut-off for the high-risk group at 3%, the prevalence of the reclassification was significantly better in the CHINA-PAR equations than in the PCE.
Subclinical vascular changes both in macro- and microcirculation would progress in ASCVD.
As a representative marker of macro-circulation, arterial stiffness measured with the baPWV has the ability to predict future CV events and total mortality [7]. Although ageing exerts a strong influence on the baPWV [18], the reference values for the baPWV and Asian evidence showed 1400 cm/s is an appropriate cut-off [17, 19]. From the microcirculation perspective, retinal microvasculopathy may reflect small vessel disease. The lower fractal dimension which reflects a sparser retinal microvascular network is associated with stroke, Alzheimer’s disease, and more diffuse and severe coronary artery disease [2023]. As demonstrated, albuminuria is significantly and independently associated with the presence and severity of atherosclerosis [12]. Therefore, we considered elevated baPWV, lower fractal dimension, and albuminuria proxies of macro- and microcirculation abnormalities.
Matthew et al. indicated that the PCE risk score provided a better estimate of racial differences in vascular function and structure than the Framingham risk score did [24]. Few former studies have assessed the association of ASCVD risk by CHINA-PAR equations with subclinical vascular changes. It may help to identify Chinese individuals at earlier time points who could benefit from early commencement or strengthening of medical treatment. The finding in the current study supports that the CHINA-PAR equations provides utility in identifying patients with elevated baPWV and low fractal dimension, in addition to a significantly improved risk assessment of all the macro- and microcirculation abnormalities as compared to PCE.
Since the CHINA-PAR equations were developed in 2016, the validations in real practice mostly focused on the northern population [5, 6]. To date, an approximately 6-fold difference in the total burden of CVD persists among provinces [1]; therefore, geographical strategies are needed to identify ASCVD throughout China in specific provinces. Our study proposed a lower cut-off point at 3% to classify individuals at high-risk for macro- and microcirculation abnormalities. The discrepancy may be attributed to the lowest rates for ASCVD in China being in the Fujian province and their dietary difference with a higher intake of proteins, unsaturated fatty acids, magnesium, zinc, and calcium. Our study also underscored that it is crucial to pay attention to those who belong to the low-risk group but as a result of the reclassification by the adjusted cut-off point, were then reclassified as high-risk, and therefore require more intense therapy.
Strengths of our study include three parameters to indicate subclinical vascular changes. We used the C-statistic and NRI to access and compare the effects of models. Our study also has a few limitations. The cross-sectional nature of the study would not clarify the causal relationship; therefore, a larger cohort in the future is required. A few subjects were not enrolled in the study because of noncompliance, leading to a possible selection bias. The use of a questionnaire is another limitation, which may cause recall bias. In addition, our results may not be generalized to other ethnicities, because the study was only validated in Chinese residents.

Conclusion

Overall, our study demonstrated that the CHINA-PAR equations rather than PCE could provide better identification of macro- and microcirculation abnormalities. A lower cut-off point for subclinical vascular changes may be selected in a population from southeast China.

Supplementary information

Supplementary information accompanies this paper at https://​doi.​org/​10.​1186/​s12872-020-01425-0.

Acknowledgements

Not applicable.
This study was performed according to the World Medical Association Declaration of Helsinki and approved by the Ethics Committee of the Fujian Provincial Hospital. A written informed consent was obtained from all individuals.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Shiwei L, Yichong L, Xinying Z, Haidong W, Peng Y, Lijun W, et al. Burden of Cardiovascular Diseases in China, 1990-2016: findings from the 2016 global burden of disease study. JAMA Cardiol. 2019, 4:342–52. Shiwei L, Yichong L, Xinying Z, Haidong W, Peng Y, Lijun W, et al. Burden of Cardiovascular Diseases in China, 1990-2016: findings from the 2016 global burden of disease study. JAMA Cardiol. 2019, 4:342–52.
2.
Zurück zum Zitat Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart Disease and stroke statistics—2019 update. Circulation. 2019;139:e56–e528.CrossRef Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart Disease and stroke statistics—2019 update. Circulation. 2019;139:e56–e528.CrossRef
3.
Zurück zum Zitat Goff DC, Lloyd-Jones DM, Bennett G, Coady S, D’agostino RB, Gibbons R, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force On Practice Guidelines. J Am Coll Cardiol. 2014;63(25 Part B):2935–59.CrossRef Goff DC, Lloyd-Jones DM, Bennett G, Coady S, D’agostino RB, Gibbons R, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force On Practice Guidelines. J Am Coll Cardiol. 2014;63(25 Part B):2935–59.CrossRef
4.
Zurück zum Zitat Yang X, Li J, Hu D, Chen J, Li Y, Huang J, Liu X, Liu F, Cao J, Shen C. Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese population: the China-PAR project (prediction for ASCVD risk in China). Circulation. 2016;134(19):1430–40.CrossRef Yang X, Li J, Hu D, Chen J, Li Y, Huang J, Liu X, Liu F, Cao J, Shen C. Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese population: the China-PAR project (prediction for ASCVD risk in China). Circulation. 2016;134(19):1430–40.CrossRef
5.
Zurück zum Zitat Tang X, Zhang D, He L, Wu N, Si Y, Cao Y, et al. Performance of atherosclerotic cardiovascular risk prediction models in a rural northern Chinese population: results from the Fangshan cohort study. Am Heart J. 2019;211:34–44.CrossRef Tang X, Zhang D, He L, Wu N, Si Y, Cao Y, et al. Performance of atherosclerotic cardiovascular risk prediction models in a rural northern Chinese population: results from the Fangshan cohort study. Am Heart J. 2019;211:34–44.CrossRef
6.
Zurück zum Zitat Zeng NM, Zheng XW, Peng H, Jiao Y, Li HM, Zhang MZ, Wang AL, Zhang YH. Validation of the China-PAR equations for cardio-cerebrovascular risk prediction in the inner Mongolian population. Biomed Environ Sci. 2018;31(6):463–6.PubMed Zeng NM, Zheng XW, Peng H, Jiao Y, Li HM, Zhang MZ, Wang AL, Zhang YH. Validation of the China-PAR equations for cardio-cerebrovascular risk prediction in the inner Mongolian population. Biomed Environ Sci. 2018;31(6):463–6.PubMed
7.
Zurück zum Zitat Sugawara J, Tanaka H. Brachial-ankle pulse wave velocity: myths, misconceptions, and realities. Pulse (Basel). 2015;3(2):106–13.CrossRef Sugawara J, Tanaka H. Brachial-ankle pulse wave velocity: myths, misconceptions, and realities. Pulse (Basel). 2015;3(2):106–13.CrossRef
8.
Zurück zum Zitat Kawasaki R, Che Azemin MZ, Kumar DK, Tan AG, Liew G, Wong TY, Mitchell P, Wang JJ. Fractal dimension of the retinal vasculature and risk of stroke: a nested case-control study. Neurology. 2011;76(20):1766–7.CrossRef Kawasaki R, Che Azemin MZ, Kumar DK, Tan AG, Liew G, Wong TY, Mitchell P, Wang JJ. Fractal dimension of the retinal vasculature and risk of stroke: a nested case-control study. Neurology. 2011;76(20):1766–7.CrossRef
9.
Zurück zum Zitat Shah SJ, Lam CSP, Svedlund S, Saraste A, Hage C, Tan RS, et al. Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF. Eur Heart J. 2018;39(37):3439–50.CrossRef Shah SJ, Lam CSP, Svedlund S, Saraste A, Hage C, Tan RS, et al. Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF. Eur Heart J. 2018;39(37):3439–50.CrossRef
10.
Zurück zum Zitat Cheng YH, Cheng HS, Tarng DC. More impact of microalbuminuria on retinopathy than moderately reduced GFR among type 2 diabetic patients. Diabetes Care. 2012;35(4):803–8.CrossRef Cheng YH, Cheng HS, Tarng DC. More impact of microalbuminuria on retinopathy than moderately reduced GFR among type 2 diabetic patients. Diabetes Care. 2012;35(4):803–8.CrossRef
11.
Zurück zum Zitat Aguilar MI, O’Meara ES, Seliger S, Longstreth WT, Hart RG, Pergola PE, et al. Albuminuria and the risk of incident stroke and stroke types in older adults. Neurology. 2010;75(15):1343–50.CrossRef Aguilar MI, O’Meara ES, Seliger S, Longstreth WT, Hart RG, Pergola PE, et al. Albuminuria and the risk of incident stroke and stroke types in older adults. Neurology. 2010;75(15):1343–50.CrossRef
12.
Zurück zum Zitat Furtner M, Kiechl S, Mair A, Seppi K, Weger S, Oberhollenzer F, Poewe W, Willeit J. Urinary albumin excretion is independently associated with carotid and femoral artery atherosclerosis in the general population. Eur Heart J. 2005;26(3):279–87.CrossRef Furtner M, Kiechl S, Mair A, Seppi K, Weger S, Oberhollenzer F, Poewe W, Willeit J. Urinary albumin excretion is independently associated with carotid and femoral artery atherosclerosis in the general population. Eur Heart J. 2005;26(3):279–87.CrossRef
13.
Zurück zum Zitat Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.CrossRef Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.CrossRef
14.
Zurück zum Zitat Kidney Disease. Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.CrossRef Kidney Disease. Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.CrossRef
15.
Zurück zum Zitat Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206–52.CrossRef Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206–52.CrossRef
16.
Zurück zum Zitat Sonne DP, Hemmingsen B. Comment on American Diabetes Association. Standards of medical Care in Diabetes—2017. Diabetes care 2017; 40 (Suppl. 1): S1–S135. Diabetes Care 2017;40(7):e92-e93. Sonne DP, Hemmingsen B. Comment on American Diabetes Association. Standards of medical Care in Diabetes—2017. Diabetes care 2017; 40 (Suppl. 1): S1–S135. Diabetes Care 2017;40(7):e92-e93.
17.
Zurück zum Zitat Yamashina A, Tomiyama H, Arai T, Hirose K, Koji Y, Hirayama Y, Yamamoto Y, Hori S. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res. 2003;26(8):615–22.CrossRef Yamashina A, Tomiyama H, Arai T, Hirose K, Koji Y, Hirayama Y, Yamamoto Y, Hori S. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res. 2003;26(8):615–22.CrossRef
18.
Zurück zum Zitat Ciccone MM, Bilianou E, Balbarini A, Gesualdo M, Ghiadoni L, Metra M, et al. Task force on: 'Early markers of atherosclerosis: influence of age and sex'. J Cardiovasc Med (Hagerstown). 2013;14(10):757–66.CrossRef Ciccone MM, Bilianou E, Balbarini A, Gesualdo M, Ghiadoni L, Metra M, et al. Task force on: 'Early markers of atherosclerosis: influence of age and sex'. J Cardiovasc Med (Hagerstown). 2013;14(10):757–66.CrossRef
19.
Zurück zum Zitat Reference Values for Arterial Stiffness Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J. 2010;31(19):2338–50.CrossRef Reference Values for Arterial Stiffness Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J. 2010;31(19):2338–50.CrossRef
20.
Zurück zum Zitat Kipli K, Hoque ME, Lim LT, Mahmood MH, Sahari SK, Sapawi R, Rajaee N, Jpseph A. A review on the extraction of quantitative retinal microvascular image feature. Comput Math Methods Med. 2018;2018:1–21.CrossRef Kipli K, Hoque ME, Lim LT, Mahmood MH, Sahari SK, Sapawi R, Rajaee N, Jpseph A. A review on the extraction of quantitative retinal microvascular image feature. Comput Math Methods Med. 2018;2018:1–21.CrossRef
21.
Zurück zum Zitat Cheung CY, Ong YT, Ikram MK, Ong SY, Li X, Hilal S, et al. Microvascular network alterations in the retina of patients with Alzheimer's disease. Alzheimer Dement. 2014;10(2):135–42.CrossRef Cheung CY, Ong YT, Ikram MK, Ong SY, Li X, Hilal S, et al. Microvascular network alterations in the retina of patients with Alzheimer's disease. Alzheimer Dement. 2014;10(2):135–42.CrossRef
22.
Zurück zum Zitat Wang SB, Mitchell P, Liew G, Wong TY, Phan K, Thiagalingam A, Joachim N, Burlutsky G. A spectrum of retinal vasculature measures and coronary artery disease. Atherosclerosis. 2018;268:215–24.CrossRef Wang SB, Mitchell P, Liew G, Wong TY, Phan K, Thiagalingam A, Joachim N, Burlutsky G. A spectrum of retinal vasculature measures and coronary artery disease. Atherosclerosis. 2018;268:215–24.CrossRef
23.
Zurück zum Zitat Liew G, Mitchell P, Rochtchina E, Wong TY, Hsu W, Lee ML, Wainwright A, Wang JJ. Fractal analysis of retinal microvasculature and coronary heart disease mortality. Eur Heart J. 2011;32(4):422–9.CrossRef Liew G, Mitchell P, Rochtchina E, Wong TY, Hsu W, Lee ML, Wainwright A, Wang JJ. Fractal analysis of retinal microvasculature and coronary heart disease mortality. Eur Heart J. 2011;32(4):422–9.CrossRef
24.
Zurück zum Zitat Topel ML, Shen J, Morris AA, Al Mheid I, Sher S, Dunbar SB, et al. Comparisons of the Framingham and pooled cohort equation risk scores for detecting subclinical vascular Disease in blacks versus whites. Am J Cardiol. 2018;121(5):564–9.CrossRef Topel ML, Shen J, Morris AA, Al Mheid I, Sher S, Dunbar SB, et al. Comparisons of the Framingham and pooled cohort equation risk scores for detecting subclinical vascular Disease in blacks versus whites. Am J Cardiol. 2018;121(5):564–9.CrossRef
Metadaten
Titel
Chinese ASCVD risk equations rather than pooled cohort equations are better to identify macro- and microcirculation abnormalities
verfasst von
Qiaowei Li
Fan Lin
Zhonghai Gao
Feng Huang
Pengli Zhu
Publikationsdatum
01.12.2020
Verlag
BioMed Central
Erschienen in
BMC Cardiovascular Disorders / Ausgabe 1/2020
Elektronische ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-020-01425-0

Weitere Artikel der Ausgabe 1/2020

BMC Cardiovascular Disorders 1/2020 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.